Skip to main content
Amir Zeki, MD, Pulmonology, Sacramento, CA

Amir A Zeki MD

Asthma & COPD, Critical Care Medicine, Clinical Pharmacology


Professor of Medicine, Internal Medicine, U.C. Davis School of Medicine

Join to View Full Profile
  • 2315 Stockton BlvdSacramento, CA 95817

  • Phone+1 916-734-3564

  • Fax+1 916-734-7924

Dr. Zeki is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • My professional objectives are simple and few: To have a beneficial impact on patient's lives locally through my clinical practice, and globally through my research. I eventually hope to build a respiratory research center or institute in Northern California that focuses on basic and translational research in pulmonary science and medicine.

Education & Training

  • University of California Davis Health
    University of California Davis HealthFellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2009
  • University of California Davis Health
    University of California Davis HealthResidency, Internal Medicine, 2001 - 2004
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2003 - 2025
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012

Publications & Presentations

PubMed

Press Mentions

  • Vaping Increases Susceptibility to Coronavirus in Mice
    Vaping Increases Susceptibility to Coronavirus in MiceJune 29th, 2021
  • Inhaling a Lower Dose of Statins Rather Than Taking Them as a Pill Could End Side-Effects
    Inhaling a Lower Dose of Statins Rather Than Taking Them as a Pill Could End Side-EffectsFebruary 8th, 2021
  • Davis Company Working on Breathable Medicine to Aid Covid-19 Recovery
    Davis Company Working on Breathable Medicine to Aid Covid-19 RecoveryJanuary 19th, 2021

Grant Support

  • Inhaled Pitavastatin for the Treatment of Asthma: A New Therapeutic ParadigmUNIVERSITY OF CALIFORNIA AT DAVIS2025–2027
  • Reducing Airway Smooth Muscle Tone Using Inhaled StatinsUNIVERSITY OF CALIFORNIA AT DAVIS2020–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: